Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan · Delayed Price · Currency is TWD 40.60
+0.30 (0.74%)
Jul 18, 2025, 1:30 PM CST
Pharmosa Biopharm Market Cap
Pharmosa Biopharm has a market cap or net worth of 5.24 billion as of July 18, 2025. Its market cap has decreased by -42.95% in one year.
Market Cap
5.24B
Enterprise Value
3.91B
Revenue
167.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
40.60
Market Cap Chart
Since February 22, 2022, Pharmosa Biopharm's market cap has increased from 4.86B to 5.24B, an increase of 7.88%. That is a compound annual growth rate of 2.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 5.24B | -23.25% |
| Dec 31, 2024 | 6.83B | -33.79% |
| Dec 29, 2023 | 10.31B | 46.19% |
| Dec 30, 2022 | 7.06B | 45.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 188.45B |
| PharmaEssentia | 182.63B |
| Bora Pharmaceuticals Co., LTD. | 87.20B |
| Lotus Pharmaceutical | 58.11B |
| Oneness Biotech | 30.90B |
| Polaris Group | 29.16B |
| Center Laboratories | 26.75B |
| TaiMed Biologics | 23.84B |